304 related articles for article (PubMed ID: 15647042)
1. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
3. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
4. Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens.
Peroni DG; Piacentini GL; Bodini A; Ress M; Costella S; Boner AL
Allergy Asthma Proc; 2005; 26(4):283-6. PubMed ID: 16270721
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
6. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
[TBL] [Abstract][Full Text] [Related]
7. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
8. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
Berkman N; Avital A; Bardach E; Springer C; Breuer R; Godfrey S
Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
[TBL] [Abstract][Full Text] [Related]
10. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
[TBL] [Abstract][Full Text] [Related]
11. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
12. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
13. Effect of montelukast on exhaled NO in asthmatic children exposed to relevant allergens.
Piacentini GL; Peroni DG; Del Giudice MM; Bodini A; Costella S; Vicentini L; Boner AL
Pediatr Allergy Immunol; 2002 Apr; 13(2):137-9. PubMed ID: 12000487
[TBL] [Abstract][Full Text] [Related]
14. Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5'-monophosphate, and exercise in asthmatic children.
Benckhuijsen J; van den Bos JW; van Velzen E; de Bruijn R; Aalbers R
Pediatr Pulmonol; 1996 Sep; 22(3):147-53. PubMed ID: 8893252
[TBL] [Abstract][Full Text] [Related]
15. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.
Covar RA; Szefler SJ; Martin RJ; Sundstrom DA; Silkoff PE; Murphy J; Young DA; Spahn JD
J Pediatr; 2003 May; 142(5):469-75. PubMed ID: 12756375
[TBL] [Abstract][Full Text] [Related]
16. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast.
Rabinovitch N; Strand M; Stuhlman K; Gelfand EW
J Allergy Clin Immunol; 2008 Jun; 121(6):1365-71. PubMed ID: 18439662
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
18. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.
Marcucci F; Passalacqua G; Canonica GW; Frati F; Salvatori S; Di cara G; Petrini I; Bernini M; Novembre E; Bernardini R; Incorvaia C; Sensi LG
Respir Med; 2007 Jul; 101(7):1600-8. PubMed ID: 17482451
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
20. Improved bronchodilator effect of deep inhalation after allergen avoidance in asthmatic children.
Milanese M; Peroni D; Costella S; Aralla R; Loiacono A; Barp C; Boner A; Brusasco V
J Allergy Clin Immunol; 2004 Sep; 114(3):505-11. PubMed ID: 15356548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
